Target intelligence / Profile preview

Gap junction beta-6 protein (Connexin 30) (CX30)

Target
CX30
Molecular classification
Gap junction protein, Ion channel, Transporter
01

Overview

Connexin 30, encoded by the GJB6 gene, is a member of the connexin family of transmembrane proteins that assemble to form gap junctions and hemichannels [3, 4]. These structures are essential for direct intercellular communication, allowing the passage of ions, small metabolites, and signaling molecules between adjacent cells [1, 15]. In the inner ear, Connexin 30 plays a critical role in potassium recycling, which is vital for the mechanotransduction process of hearing [3, 11]. Mutations in the GJB6 gene are a major cause of nonsyndromic hearing loss and Clouston syndrome, a skin disorder characterized by hair loss and nail dystrophy [3, 10]. In the central nervous system, Connexin 30 is primarily expressed in astrocytes, where it regulates synaptic strength and glutamate transport [2, 12]. It has also been implicated in cancer, specifically glioblastoma, where it may act as a tumor suppressor but also contribute to radiation resistance [7, 16]. Pharmacological modulation of Connexin 30 is being explored for neurological and psychiatric conditions, although achieving isoform specificity remains a significant therapeutic challenge [2, 5, 15].

Other names
GJB6Connexin-30Gap junction protein beta 6DFNA3DFNA3BDFNB1BECTD2ED2EDHHEDHED2
02

Mechanism of action

Gap junction blocker, Hemichannel inhibitor, Modulation of astroglial glutamate transport

03

Biological functions

Cell-cell communicationIon transportPotassium recyclingATP releaseRegulation of synaptic strengthSkin developmentCell adhesion and migration
04

Disease associations

Nonsyndromic hearing lossClouston syndrome (Hidrotic ectodermal dysplasia 2)GlioblastomaPsoriasisDepressionSkin disorders
05

Safety considerations

Lack of isoform specificity (off-target effects on Cx43 or Cx26)Potential for systemic toxicity due to widespread expressionComplex role in cancer (tumor suppression vs. radiation resistance)
06

Interacting drugs

Carbenoxolone

7 more in the full profile.

07

Biomarkers

GJB6 gene mutationsGJB6 gene deletionsConnexin 30 expression levels

Beyond the preview

Go deeper on Gap junction beta-6 protein (Connexin 30) (CX30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gap junction beta-6 protein (Connexin 30) (CX30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call